24.3 Bacterial Infections of the Gastrointestinal Tract

Foodborne Bacterial Infections

Bacterial infections of the GI tract are among the most common infectious diseases worldwide. They spread primarily through contaminated food and water, and the illness they cause ranges from self-limiting diarrhea to severe, life-threatening conditions. Knowing the specific organisms, their toxins, and how they damage the gut is essential for diagnosis and treatment.

Characteristics of Foodborne Bacterial Infections

Salmonella

Salmonella is a Gram-negative, facultative anaerobic rod. It spreads through contaminated poultry, eggs, water, and contact with infected animals (reptiles are a classic source). After an incubation period of 12–72 hours, it causes diarrhea, fever, abdominal cramps, and vomiting.

• Most cases are self-limiting in healthy adults.
• Young children, the elderly, and immunocompromised individuals are at higher risk for invasive disease, where bacteria can spread beyond the gut into the bloodstream.

Escherichia coli (E. coli)

Most E. coli strains are harmless members of normal gut flora, but certain pathogenic strains cause serious illness. The most clinically significant is E. coli O157:H7, a Shiga toxin-producing strain (STEC).

• Gram-negative, facultative anaerobic rod
• Spreads through undercooked ground beef, contaminated water, and contact with cattle
• Symptoms appear 3–4 days after exposure: watery or bloody diarrhea, abdominal cramps, vomiting, and sometimes fever
• The major concern is hemolytic uremic syndrome (HUS), where Shiga toxin damages blood vessel walls in the kidneys, leading to kidney failure, hemolytic anemia, and low platelet counts. HUS is most common in children under 5.
• Antibiotics are generally not recommended for STEC infections because killing the bacteria can release more Shiga toxin and increase the risk of HUS.

Campylobacter

Campylobacter jejuni is the leading cause of bacterial gastroenteritis worldwide. Unlike the other organisms here, it's microaerophilic, meaning it grows best at low oxygen levels (around 5% $O_2$).

• Gram-negative, spiral-shaped bacterium
• Spreads through undercooked poultry, contaminated water, and contact with infected animals
• Symptoms appear 2–5 days after exposure: diarrhea (often bloody), abdominal pain, fever, nausea, and vomiting
• A rare but serious complication is Guillain-Barré syndrome (GBS), an autoimmune disorder where antibodies against Campylobacter cross-react with nerve gangliosides, causing ascending muscle weakness and paralysis. This molecular mimicry is a commonly tested concept.

Bacterial Toxins and Gastrointestinal Illnesses

Bacterial Toxins in Gastrointestinal Illnesses

Cholera

Cholera is caused by Vibrio cholerae, a Gram-negative, comma-shaped bacterium found in contaminated water, particularly in areas with poor sanitation. The disease itself is driven almost entirely by cholera toxin (CT), not by tissue invasion.

Here's how cholera toxin works, step by step:

1. The toxin has an AB structure: five B subunits and one A subunit.
2. The B subunits bind to GM1 ganglioside receptors on the surface of intestinal epithelial cells.
3. The A subunit enters the cell and permanently activates adenylate cyclase.
4. This causes a sustained increase in intracellular cAMP levels.
5. Elevated cAMP forces chloride channels open, pumping $Cl^-$ ions into the intestinal lumen.
6. Water follows the chloride by osmosis, producing massive fluid secretion.

The result is profuse, watery diarrhea often described as "rice-water stool" (pale, flecked with mucus). Patients can lose liters of fluid per hour, making severe dehydration and electrolyte imbalance the primary cause of death. Treatment centers on aggressive fluid and electrolyte replacement, primarily oral rehydration therapy (ORT).

Clostridioides difficile (C. difficile) Infection

C. difficile is a Gram-positive, obligate anaerobic, spore-forming bacterium. The spores are extremely resistant to heat, drying, and alcohol-based hand sanitizers, which is why C. diff spreads so readily in healthcare settings.

The classic scenario: a patient receives broad-spectrum antibiotics that wipe out normal gut flora, removing the competitive barrier that normally keeps C. difficile in check. With the competition gone, C. difficile proliferates and produces toxins.

C. difficile produces two main toxins:

• Toxin A (TcdA) and Toxin B (TcdB) are large glucosyltransferases that inactivate Rho GTPases inside intestinal epithelial cells.
• Rho GTPases normally maintain the actin cytoskeleton and tight junctions between cells.
• When these are disrupted, cells round up and detach, tight junctions break down, and gut permeability increases dramatically.
• The result is inflammation, cell death, and fluid accumulation.

Symptoms range from mild watery diarrhea to severe complications:

• Pseudomembranous colitis: raised, yellowish-white plaques of fibrin, mucus, and dead cells visible on colonoscopy
• Toxic megacolon: dangerous dilation of the colon with risk of perforation

Treatment for C. difficile involves stopping the offending antibiotic when possible and starting targeted therapy. Oral vancomycin or fidaxomicin are first-line treatments (not IV vancomycin, which doesn't reach the gut lumen). For recurrent infections, fecal microbiota transplant (FMT) has shown high success rates by restoring normal gut flora.

Mechanisms of Bacterial Toxins in Gastrointestinal Infections

Understanding toxin categories helps you predict clinical presentation:

• Enterotoxins act on intestinal epithelial cells to increase fluid secretion without destroying tissue. They typically cause profuse, watery diarrhea. Cholera toxin is the classic example.
• Cytotoxins directly damage or kill host cells, causing tissue destruction and inflammation. They tend to produce bloody diarrhea. Shiga toxin (from STEC) and C. difficile toxins fall into this category.
• Enteric pathogens is a broader term for any bacteria that specifically infect the GI tract, whether through toxin production, direct invasion of intestinal cells, or both.

Diagnosis and Treatment of Bacterial Gastroenteritis

Diagnosis and Treatment of Bacterial Gastroenteritis

Diagnostic Methods

• Stool culture: The traditional approach. Bacteria from a stool sample are grown on selective media in the lab. This allows identification and antibiotic susceptibility testing, but results take 48–72 hours.
• Molecular tests (PCR): Detect bacterial DNA directly from stool samples. Much faster than culture (results in hours) and highly sensitive. Multiplex PCR panels can test for several pathogens at once.
• Toxin assays (EIA/ELISA): Detect specific toxins in stool. Commonly used for C. difficile (testing for toxins A and B) and sometimes combined with a GDH (glutamate dehydrogenase) screening test for a two-step diagnostic algorithm.
• Imaging (CT scan): Not used to identify the bacterium, but to assess complications like colonic wall thickening, pseudomembranous colitis, or toxic megacolon.

Treatment Approaches

Supportive care is the foundation for most bacterial gastroenteritis:

• Oral rehydration with fluids and electrolytes is the single most important intervention, especially in cholera and pediatric cases.
• Gradually reintroduce solid foods as symptoms improve.

Antibiotics are not always appropriate:

• Many infections (including most Salmonella gastroenteritis) resolve without antibiotics.
• Antibiotics are reserved for severe cases, high-risk patients, or specific organisms.
• Examples: ciprofloxacin or azithromycin for Campylobacter; oral vancomycin or fidaxomicin for C. difficile.
• Antimicrobial resistance is a growing concern. Fluoroquinolone-resistant Campylobacter strains are increasingly common, which is why susceptibility testing matters.

Antidiarrheal agents (loperamide, bismuth subsalicylate):

• Can provide symptom relief in mild, watery diarrhea.
• Avoid in cases of bloody diarrhea or fever. These agents slow gut motility, which can trap invasive bacteria or toxins in the intestine and worsen disease. This is especially important with STEC infections, where slowed clearance may increase HUS risk.

Probiotics:

• May help restore normal gut flora and shorten symptom duration in some cases.
• Evidence is strongest for antibiotic-associated diarrhea prevention.
• Specific strains and optimal dosing are still being studied.

Transmission and Prevention

Most GI bacterial pathogens spread through the fecal-oral route: contaminated food, water, or direct contact with fecal matter.

Key prevention strategies:

• Hand hygiene: Soap and water is preferred over alcohol-based sanitizers for C. difficile (spores resist alcohol).
• Safe food handling: Cook meats to proper internal temperatures, avoid cross-contamination between raw and cooked foods, and refrigerate perishables promptly.
• Clean water and sanitation: Critical for preventing cholera and other waterborne infections, especially in resource-limited settings.
• Antibiotic stewardship: Using antibiotics only when necessary reduces the risk of C. difficile infection and slows the development of antimicrobial resistance.